ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,523,809 | -64.0% | 329,601 | -42.6% | 0.02% | -61.9% |
| Q2 2023 | $4,236,597 | -0.3% | 573,915 | +18.9% | 0.04% | -4.5% |
| Q1 2023 | $4,249,473 | -26.3% | 482,633 | -6.0% | 0.04% | -30.2% |
| Q4 2022 | $5,767,384 | -9.3% | 513,564 | -2.7% | 0.06% | -12.5% |
| Q3 2022 | $6,361,691 | +39.7% | 527,660 | +48.9% | 0.07% | +41.2% |
| Q2 2022 | $4,554,309 | +6.5% | 354,476 | -0.6% | 0.05% | +21.4% |
| Q1 2022 | $4,276,264 | +50.5% | 356,626 | +97.1% | 0.04% | +50.0% |
| Q4 2021 | $2,840,479 | – | 180,955 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |